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Summary.-Peripheral leucocytes from nasopharyngeal carcinoma (NPC) patients
and control subjects, which included healthy subjects and patients with other cancers,
have been tested against PPD and a panel of extracts from Raji cells and pooled
NPC biopsies, using the blast transformation and the macrophage migration inhibi-
tion assays. The results of both assays indicated that the in vitro cell-mediated
immune (CMI) responses to the Raji-cell extracts and NPC-biopsy extracts were
associated with NPC. However, the peripheral leucocytes from NPC patients and
control subjects responded similarly to PPD. These results are in general accord
with the skin tests reported by Levine et al. (1976) and Ho, Ng and Kwan (1977b).
The antigenic specificity of the NPC-associated CMI responses remains, however,
to be resolved, as the extracts used in these or inthe in vivo CMI studies were hetero-
geneous mixtures.
NPC is closely associated with Epstein-
Barr virus (EBV). This is made evident
by: (1) NPC patients showing a different
pattern of humoral immune responses to
EBV antigens from that shown by
control groups ofnon-NPC subjects (Henle
et al., 1970; Henle et al., 1973; de Schryver
et al., 1974; de-The et al., 1975; Ho et
al., 1976; Ho et al., 1977b; Ng, Ho and
Kwan, 1977) and (2) the persistent
presence of EBV genomes and EBV
nuclear antigen(s) in NPC cells (Des-
granges et al., 1975; Huang et al., 1974;
Wolf, Zur Hausen and Becker, 1973;
Klein et al., 1974). The resident EBV
genomes may be activated to synthesize
early viral antigens and/or virus particles
when NPC cells have been treated with
IUdR and BUdR respectively (Glaser et
al., 1976; Trumper, Epstein and Gio-
vanella, 1976). A transforming strain
of EBV was frequently found to stimulate
sustained cell outgrowth from normal
nasopharyngeal epithelial explants in-
fected in vitro with this virus. Stimulation
was, however, more rarely observed with
similarly treated explants from tonsillar
mucosa, NPC or OC (other cancer) biopsy
specimens (Huang et al., 1977). These
observations suggest that EBV might
be a causal agent in NPC.
In view of the above, NPC patients
may be expected to have acquired CMI
against EBV antigens; as was indeed
suggested by the results of in vivo CMI
studies of Levine et al. (1976) and Ho et
al. (1977a). Chu et al. (1967) showed that
lymphocytes of NPC patients were cyto-
toxic to autochthonous tumour cells,
and suggested that therefore an NPC-
related CMI may also exist. A detailed
knowledge of antigenic specificities of
the NPC-related and the EBV-related
CMI would be of importance. There are
two classes of EBV antigens which occur
in different lymphoblastoid cell lines
harbouring EBV genomes. One is pro-
duced during viral lytic cycle and occurs
in producer cell lines and, to a lesser
extent, in non-producer cell lines treatedW. S. NG, M. H. NG, H. C. HO AND J. P. LAMELIN
with halogenated nucleotides (Hampar et
al., 1973; Gerber, 1972) or exogenous
EBV (Henle, Henle and Klein, 1971).
The other class of EBV antigens (i.e.
EB nuclear antigen (EBNA) occurs in
both producer and untreated non-pro-
ducer cell lines, such as Raji (Reedman
and Klein, 1973), and these antigens
are not associated with the lytic cycle
of the virus. Lai, Alpers and Mackay-
Scollay (1975) showed that EBV sero-
positive, but not seronegative, subjects
display positive in vitro CMI responses to
an extract of the EBVI-producing P3HR-1
cell line. However, neither grou) of
subjects responded to a similar extract
of a non-EBV-producing Raji cell line.
The P3HR-1 extract was also shown to
contain infective EB virions. It seems
likely, therefore, that the in vitro CMI
responses observed by these authors may
have antigenic specificities against those
EBV antigens produced during the viral
lytic cycle. In Hong Kong, a prepon-
derance of NPC patients as well as non-
NPC subjects are EBV-seropositive (Ho
et al., 1977b) and it nmay be anticipated
that both groups of subjects are also
likely to have acquired CMI to the P3HR-I
extracts. Nkrumah et al. (1976) reported
that patients with Burkitt's lymphoma
showed a positive skin reaction against
a membrane extract of Raji cell, aind
that the antigenic specificities of such
reactivity did not appear to be directed
against EBNA. Cytotoxic effector cells
specific for Raji cells have also been
found in the peripheral blood of patients
with infectious mononucleosis during the
acute phase of the disease (Svedmyr
and Jondal, 1975). It seems possible
from these studies and from others with
animal tumour viruses (Habel, 1969)
that there may exist a new class ofplasma-
membrane-associated EBV antigens which
has not yet been defined serologically.
In view of the close association of NPC
with EBV, it is of obvious interest to
study in vitro CMI to the latter class of
antigens, and to test its possible relation-
ship with CMI against NPC cells. To this
end, we have prepared extracts from Raji
cells by ionic-shock treatments which
result in the release of a heterogeneous
mixture of cell-surface proteins (Lo et
al., 1976). The extracts do not contain
detectable EBNA and the cells remain
intact after these treatments. In results
to be reported subsequently, we have
shown that a majority of proteins in
these extracts contain sialic-acid residues.
We here report results of our in vitro
CMI studies with these Raji-cell extracts,
and the hypertonic-KCl extracts of NPC
biopsy material. In vitro CMI responses
to these extracts, but not to PPD, are
associated with NPC.
METHODS AND MATERIALS
Peripheral leucocyte cultures. -12 ml of
of peripheral blood obtained from NPC,
patients writh other cancers (OC) or healthy
subjects (HS) wNas layered over an equal
volume of Lymphoprep (Neygaard Corp.
A/S, Oslo, Norway) and centrifuged at
400 g for 30 min. The leucocyte-rich interface
was harvested, washed twice at room tem-
perature with Hanks' buffered salt solution
(HBSS) once with RPMI-1640 supplemented
with 15% foetal calf serum (Grand Island
Biological Corp., U.S.A.) and suspended in
growth medium at a cell density of 0-6-
0-8 x 106 cells/ml. 0 4 ml aliquots of this
cell suspension w%ere cultured in triplicate,
in the presence or absence of 0-1 ml of
antigen, for 5 days at 37°C in 5% CO2.
The culture supernatants wrere kept at
-20°C for the macrophage migration in-
hibition (MIF) assay while the cells were
resuspended in 0 5 ml of growth medium
and labelled for 16 h with 5 juCi of 3H-
thymidine (TdR) which has a specific radio-
activity of 13 Ci/mM TdR (The Radio-
chemical Centre, Amersham, England). The
cells were harvested, washed once with
HBSS, dissolved in 0-1 M NaOH and pre-
cipitated in 500 trichloroacetic acid (TCA)
after neutralization of the solution with
IM HCl. The precipitated material was
collected onto GF/C glass-fibre filters (2.4
cm, Whatman Ltd, England) and its radio-
activity counted in a liquid scintillator
using 5 ml of scintillation fluid (Aquasol,
New England Nuclear, U.S.A.). BT response
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was expressed as stimulation index (SI)
which is the ratio of the average radio-
activity incorporated by the test to that by
the control cultures.
Macrophage migration inhibition assay.-
This was performed as described by Rocklin,
Meyers and David (1970). The culture
supernatants were used undiluted. For each
batch of guinea-pig macrophage used, con-
trols were set up using the antigens or the
extracts adjusted to the same concentration
as used in the leucocyte cultures (reconsti-
tuted antigen controls). The extent of
macrophage migration in the presence of
the culture supernatant or the reconstituted
antigens was compared with and expressed
as a percentage of that observed with the
macrophage alone.
Subjects.-80 NPC and 77 OC patients
with histologically confirmed cases of the
respective cancers and 21 HS were studied.
The average age and the sexes of each of
these groups of subjects are summarized in
Table I.
Antigen and extracts.-The Raji-cell ex-
tracts were prepared with cells harvested
from cultures at log phase of growth accord-
ing to Lo et al. (1976). TS were obtained by
treating these cells with the Tris-HCl buffer
(Tris-HCl, 0O02M in 10% glycerol, pH 7.2).
These cells were further treated with the
EDTA buffer (Tris-HCl, 0-02M; EDTA,
10 mM; NaCl, 0-2M; pH 7.2) and the resulting
extract is referred to as ES. These extracts
had been shown to consist mainly of surface
components from Raji cells (Lo et al., 1976).
PPD was a gift from Dr J. Lawton pre-
pared in the Ministry ofAgriculture, Fisheries
and Food, Central Veterinary Laboratory,
Surrey, England.
Nasopharyngeal biopsies of 70 individuals
with histologically confirmed cases of NPC
have been stored at -70°C over a period
varying from 1-12 months. These biopsies,
wet weight 4-3 g, were washed once with
TKM buffer (Tris-HCl, 0 01 M, KCI, 0-1M,
MgCl2, 0-01 M, pH 7.4) at room temperature
and then ground with 10 g of acid-washed
sand, using a mortar and pestle. The sand
was sedimented and the tissue suspension
adjusted to 15 ml with TKM and cooled
to 4°C. All subsequent operations were
carried out at 40C.
The tissue suspension was homogenized
in a glass tissue grinder using a tight-fitting
teflon pestle (0-15 mm clearance, Arthur
48
Thomas Co., U.S.A.) until 90% cell breakage,
as indicated by phase-contrast microscopy.
The homogenates were layered over 5 ml
of TKM containing 0-5M sucrose and centri-
fuged at 2000 g for 10 min. The pellet was
briefly homogenized (10 strokes) in 5 ml
of TKM and again sedimented through a
5ml layer of TKM-0-5M sucrose. The pellet,
which was shown by phase-contrast micro-
scopy to be composed of nuclei and a large
membrane fragment is referred to hereafter
as 2p. The low-speed supernatant and
washings were pooled and centrifuged at
15,000 g for 60 min. The resulting super-
natant was discarded, and the pellet which
contained the membrane fragments was
referred to as 12p.
To effect their solubilization, 2p and 12p
were briefly homogenized (10 strokes) in
2 ml of EDTA-KC1 buffer (KCI 2M, EDTA
20 mm, Tris-HCl, 20 m, pH 7.2), and
allowed to stand for 1 h. The suspensions
were centrifuged at 15,000 g for 60 min
and the resulting supernatant aspirated.
The pellets were similarly extracted twice
for one hour and then overnight. Theresulting
extracts were pooled, centrifuged at 100,000 g
for 2 h and the supernatants were referred
to as 2PE and 12PE respectively. These
were dialysed extensively against PBS before
filtering through millipore (0.45 ,um) and
the extracts were stored in 0-5ml aliquots
at - 20°C until use.
Serially diluted aliquots of PPD, the
extracts of Raji cells and NPC biopsies
were added to the peripheral leucocyte
cultures from 26 NPC patients, 8 of whom
had local tumours (Stages I and II) and
18 regional. The concentrations of PPD
and extracts eliciting optimal BT responses
are shown in Table I and these concentra-
tions were used throughout the subsequent
studies.
RESULTS
In the first series, the peripheral
leucocytes from 24 NPC and 20 OC
patients were tested concurrently for
their BT and MIF responses to PPD,
Raji-cell extracts (TS and ES) and NPC
biopsy extracts (2PE and 12PE). To
determine a cut-off value in scoring the
MIF assays, macrophage migration in
the presence and absence of antigens.
were compared. It was shown that the
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TABLE I.-Optimal Concentration of PPD
and Extracts as Determined by the
Blastogenic Responses shown by the
Peripheral Leucocytes from NPC Pa-
tients
Antigens
or
extracts
PPD
TS
ES
2PE
12PE
Number of
patients
studied
12
14
14
12
12
Optimal
concentration
(,ug/ml culture)
6
10
6
26
10
antigens alone, adjusted to the same
concentrations as used in the respective
leucocyte cultures, did not significantly
affect the migration of the guinea-pig
macrophages, and a cut-off value of
75% migration or less allowed the scoring
of the results of the MIF assay at better
than the 95% confidence limit (Table II).
The spontaneous rate of incorporation
of [3H]TdR by control cultures of leuco-
cytes from different patients varied from
01-43*5 x 103 ct/min. To allow com-
parison of results, BT responses in the
presence of antigens were therefore ex-
pressed as SI's (stimulation indices).
The MIF responses to PPD and the
extracts observed in the NPC and OC
patients are shown in Fig. 1. The results
were compared with the concurrent BT
responses. Using different cut-off values
of SI, the patients were separated into
those showing positive (Type A) or nega-
tive (Type B) responses by both assays
(i.e. the concordant responses), and those
showing positive responses in only MIF
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FiG. 1.-Blastogenic response (measured as
SI) and production of Guinea-pig Macro-
phage Migration Inhibition Factor (MIF)
by peripheral leucocytes obtained from
NPC (x) and OC patients (0) cultured
in the presence of PPD, the Raji-cell
extracts, TS and ES, and the NPC-biopsy
extracts, 2PE and 12PE.
(Type C), or only BT (Type D) assays
(i.e. the discordant responses). The mean
ratio of patients showing the concordant
and discordant responses observed with
PPD and the extracts depended on the
SI cut-off values (Fig. 2). The maximum
ratio occurred at a cut-off value of 1.6,
TABLE II.-Direct Effect ofPPD and Extracts on the Migration of Guinea-pig
Macrophages
Extracts
PPD
TS
ES
2PE
12PE
Concentration
(,g/ml culture)
6
10
6
26
10
Expt. no.
11
10
10
7
7
*Mean %
migration
(±s.d.)
106 -5±9-9
101*4±12.9
97-6±10-5
95-3±8-5
101*7±11 0
tConfidence
limit of
scoring
>0-99
>0 95
>0*95
>0 95
>0 95
* % migration is average migration ofguinea-pig macrophage (mm)2 in the presence to that in the absence
of the extracts or PPD, as% of that in their absence.
t A positive MIF was scored when the test cultures showed < 75% migration (i.e. > 25% inhibition
of migration).
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FIG. 2.-Correlation between the results ob-
tained by the Blast Transformation (BT)
and the Macrophage Migration Inhibition
Assays, using different Stimulation Index
(SI) as cut-off values to score the BT
responses. Mean ratio of concordant to
discordant responders was obtained, for
a given cut-off SI value, from the ratios
observed with PPD, TS, ES, 2PE and
12PE.
reflecting the maximum correlation of
the results obtained by the MIF and BT
assays. The lower ratio of concordant
to discordant responders observed at the
lower SI cut-off values might indicate a
corresponding increase in the number of
patients showing false positive BT re-
sponses, while at the higher cut-off SI
values, it might be anticipated that
a correspondingly increased number of
patients would show false negative BT
responses. In the subsequent analysis,
therefore, SI > 1 6 was scored as a
positive BT response.
The in vitro CMI responses to PPD
and the extracts, by the NPC and the
OC patients are compared (Fig. 3). The
BT responses to PPD and the NPC
biopsy extract, 2PE, were not signifi-
cantly different between the 2 groups
of patients, but a significantly greater
number ofNPC patients displayed positive
responses to TS, ES and 12PE. The
2 groups of patients were not signifi-
cantly different in their MIF responses
to PPD but significantly more NPC
than OC patients showed positive
MIF response to TS, ES, 2PE and 12PE.
Among the concordant responders, the
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FIG. 3.-Comparison of Blast Transforma-
tion (BT), production of Macrophage Inhibition Factor (MIF) and both together, observed with Peripheral Leucocytes from
NPC (O) and OC (X) patients cultured
in the presence of PPD, the Raji-cell extracts, TS and ES, and the NPC-biopsy extracts, 2PE and 12PE.
2 groups of patients differed signifi-
cantly in their responses to all 4 extracts
but not to PPD. The discordant responses
were probably due either to a weak CMI
of the patients tested or to inherent
artifacts ofthe assays. Inthe firstinstance, it might be anticipated that the results
obtained by both assays were random, depending on the relative sensitivity of
the assays. In the latter instance, as
both assays differ in nature, assay arti-
facts may be expected to become apparent under different sets ofexperimental condi-
tions and thereby giving rise to dis-
cordant responses. However, these possi- bilities are not readily distinguishable from one another, and patients who
showed discordant responses were ex-
cluded from consideration. The number
of NPC and OC patients thus excluded
from the top section of Fig. 3, were
10/44 tested for their responses against PPD, 9/39 for TS, 15/38 for ES, 9/30 for 2PE and 7/30 for 12PE. (These can
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TABLE III.-Subjects Tested on BT Assay Only
Subjects
NPC patients (Stages I and II)
NPC patients (Stages III and IV)
*Other cancer patients (OC)
Healthy subjects (HS)
Number A
Male Female Total
17 3 20
44 16 60
42 15 57
15 6 21
Mean age i s.d.
(yrs)
45-2+9*3
48-1±10-1
57 *0+10-6
38-8±11*2
* The OC patients were made up of 15 with Ca bronchus, 11 Ca larynx, 4 Ca tongue, 2 each with Ca
cervix, oesophagus and basal cells, 2 with malignant thymoma, 3 with lymphoma, 1 each with Ca of hard
palate, soft palate, hypopharynx, maxillary antrum, parotid gland, epiglottis, maxillary sinus, testis,
urinary bladder, supraglottis, vocal cord, bone axilla and 1 patient each with Hodgkin's disease, metastatic
carcinoma and fibrosarcoma.
TABLE IV.-CoMpartson of the Blastogenic Responses shown by Leucocytes from Other
Cancer Patients (OC) and Healthy Subjects (1IS) Cultured in the Presence of PPD,
the Raji-cell Extracts, TS and ES, or the NPC-biopsies Extracts, 2PE and 12PE
oc
t~~~
Antigens
PPD
TS
ES
2PE
12PE
No.
57
51
51
57
56
Median
SI
1*5
0 9
0-8
1*4
1*2
No.
13
21
21
20
20
be seen as categories in C and D in
Fig. 1.)
In a more extensive study, involving
a large number of NPC and OC patients
and HS, Table III, only the BT assay
was used. The results thus obtained were
analysed by the Wilcoxon's two-sample
rank-sum test as well as by the Chi-square-
test using SI 1X6 as the cut-off value.
Neither method of comparison revealed
a significant difference between OC and
HS in the distribution of SI with PPD
or the extracts. These 2 groups were,
therefore, combined as the control groups
(Table IV). NPC patients as a whole,
or those with regional tumours, differed
significantly from the controls in their
BT responses to TS, ES, 2PE and 12PE,
but not to PPD, as indicated by both
methods of comparison (Table V(a) and
(b)). NPC patients with local tumours,
however, showed similar responses to
PPD, 2PE and 12PE, but the responses
to TS and ES differed significantly between
these 2 groups (Table V(c)). These
results suggest therefore that the BT
responses, at least to the biopsy extracts,
HS
Comparison (P)
Median , _- _A A
SI Wilcoxon Chi-square
2*0 ns ns
1*0 ns ns
0 *8 ns ns
1-1 ns ns
0 9 ns ns
may be more strongly associated with
the later stages of NPC.
DISCUSSION
The blast transformation (BT) assay,
particularly when adapted for micro-
cultures, provides a convenient means
of testing for in vitro CMI, but the
evaluation of data so obtained presents
certain difficulties. One concerns the
different levels of spontaneous activity
of the control unstimulated cultures,
which make it necessary, as in the present
instance, to measure BT responses in
terms of SI rather than the absolute
amount of radioactivity incorporated.
The choice of a cut-off value to score BT
responses presents yet another difficulty.
To apply this assay to the evaluation
of the CMI of an individual against a
known antigen, a large-scale population
study should first be carried out. From
the results thus obtained, density func-
tions of SI's from a sensitized and non-
sensitized populations may be generated.
An appropriate cut-off value of SI may
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TABLE V. CoMparison of the Blastogenic Responses shown by Leucocytes from NPC
Patients and Control Subjects (C) which Included Patients with Other Cancers (OC)
and Healthy Subjects (HS) Cultured in the Presence of PPD, the Raji-cell Extracts,
TS and ES, or the NPC-biopsies Extracts, 2PE and 12PE
NPC
Median
No. SI
80 2-0
69 1-4
68 1-3
56 2-2
56 1-7
C
Median
No. SI
70 1-7
72 0 9
72 0-8
77 1-3
76 1-2
Comparison (P)
Wilcoxon Chi-square
ns
0 0002
00001
0 0005
0-0014
ns
0O01
0-01
0-01
0*05
(b) NPC stages III and IV vs C
NPC III and IV C
A,
No.
70
72
72
77
76
Median
SI
1-7
0 9
0-8
1-3
1-2
Comparison (P)
Wilcoxon Chi-square
ns
0 0005
0-0001
0*0001
0 0002
(c) NPC stages I and II vs C
NPC I and II
Median
Antigens No. SI
PPD 20 2 0
TS 16 1-4
ES 15 1-2
2PE 13 1-6
12PE 13 1-4
C
Median
No. SI
70 1-7
72 0 9
72 0-8
77 1-3
76 1-2
Comparison (P)
Wilcoxon Chi-square
ns
0 0088
0O0001
ns
ns
ns
ns
0-01
ns
ns
then be chosen on the basis of such
distribution patterns, but the diagnostic
value of such tests will depend
on the separation between the density
functions. In the case of a heterogeneous
mixture of unknown antigenicity, such
as the extracts used for the present study,
it may not be possible to decide on an
objective cut-off value which delineates
the sensitized and non-sensitized subjects.
As our present interest lies, however, in
differences between the NPC patients
and the control group, it is not essential
that such a cut-off value be established.
Instead, the distribution of SI values
with a given antigen preparation in 2
groups of subjects may be directly com-
pared by the Wilcoxon's two-sample
rank-sum test. Such differences may also
be reflected in the different frequencies
of individuals from the 2 groups having
an SI exceeding or equal to a certain
arbitrarily chosen value. Such an arbitrary
cut-off value may be chosen empirically,
because it gives the best discrimination
between the 2 groups of subjects
tested. In the present instance, it was
chosen as a value which gave an optimal
concordance between the results of the
BT and MIF assays. If the discordance
is due to assay artifacts, as discussed
earlier, this value would approximate
the true cut-off value. Valdimarsson et
al. (1972) reported that lymphocytes
from a severe chronic case of muco-
cutaneous candidiasis of the granulo-
matous variety, responded to in vitro
challenge with soluble candida antigens
by elaboration of MIF but not by in-
creased DNA synthesis. Eife et al. (1974)
(a) NPC vs C
Antigens
PPD
TS
ES
2PE
12PE
Antigens
PPD
TS
ES
2PE
12PE
No.
60
53
53
43
43
Median
SI
1-9
1-4
1-3
2 -4
1-8
ns
0O01
001
0-01
0 05
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also found discordant BT responses and
lymphotoxin production in neonatal lym-
phocytes. It seems possible, therefore,
that the present discordance may reflect
an inherent characteristic in the immunity
of some of the subjects. Other possibilities
giving rise to assay discordance may
include toxicity of the antigen prepara-
tions, as suggested by the low median
SI values observed with TS and ES.
In the latter instance, it is necessary
to assume that antigen toxicity affects
the two assays differently.
It must be emphasized that the cut-off
value as used herein is arbitrarily chosen
to allow group comparison, and it is not
intended for testing in vitro CMI of
individual subjects. To facilitate the
differentiation of individual NPC patients
and control subjects, Professor John
Aitchinson has carried out a parametric
analysis of the present data, in which
density function of SI values obtained
with all 5 antigen preparations were
generated simultaneously for the NPC
and the non-NPC groups. BT responses
to the 5 antigen preparations observed
inindividual subjects were then compared
to these 2 density functions. It was
found that about 80% of the control
subjects show response profiles which
fit in with the density functions for the
non-NPC group, whilst about 50% of
the NPC patients have an "NPC-like"
pattern of responses.
The comparisons of the in vitro CMI
responses of NPC patients and control
subjects to PPD and the extracts of Raji
cells and NPC biopsies are summarized
in Table VI. It is apparent that the NPC
patients and the control subjects do not
differ in their responses to PPD. By
contrast, the responses elicited by the
Raji-cells and the NPC-biopsy extracts
appear to be associated with NPC. Thus,
a significantly greater number of NPC
than OC patients showed positive MIF
responses to all 4 extracts, and positive
BT responsesto onlytheRaji-cell extracts.
Among the concordant responders, a
preponderance oftheNPC patients showed
positive MIF and BT responses to all 4
extracts, while the OC patients almost
uniformly showed a negative response.
In the larger series using the BT assay
alone, the distribution patterns of SI
values observed with the NPC patients
and the control subjects using these
extracts were found to be significantly
different by Wilcoxon's two-sample rank-
sum test. There was also a significantly
greater number of NPC patients than
control subjects showing positive BT
responses (SI > 1.6) to each of the 4
extracts. A positive response to the
biopsy extracts (2PE and 12PE) appeared
TABLE VI.-CoMparison of In vitro CMI Responses between NPC Patients and Control
Groups, Patients with Other Cancer (OC) or OC + HS (C)
Method of
Groups compared comparison
(1)NPCvsOC *SI>1-6
(2) NPC vs C SI>1I6
NPC vs C Wilcoxon
(3) NPC (I and II) vs C SI> 1* 6
NPC (I and II) vs C Wilcoxon
(4) NPC (III and IV) vs C SI> I * 6
NPC (III and IV) vs C Wilcoxon
MIF (5) NPC vs OC
MIF/BT (6) NPC vs OC
Antigens (P)
PPD TS ES 2PE 12PE
tns <0-01 <0-01 ns <0-02
ns <0-01 <0-01 <0-01 <0 05
ns 0*0002 0*0001 0*0005 0*0014
ns ns <0*01 ns ns
ns 0*0088 0*0001 ns ns
ns <0-01 <0-01 <0-01 <0-05
ns 0*0005 0*0001 0*0001 0*0002
*% migration,< 75 ns <0*01 <0*01 <0*01 <0*01
*% migration,< 75 ns <0*01 <0*01 <0*01 <0*01
and SI>1*6
* Chi square analysis using SI > 1 * 6 or average percent migration < 75 as the appropriate cut-off values.
t Not significant.
In vitro
CMI
assay
BT
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more frequently at the later stage of the
disease.
The ,present observations with the
Raji-cell extracts are consistent with
the findings of Levine et al. (1976) and
Ho et al. (1977b). Both groups of authors
observed that there was a significantly
greater number of NPC patients than
control subjects who showed positive skin
reactivity to the membrane extract of the
EBV-carrying lymphoblastoid cell line,
HKLy28. In a longitudinal study of NPC
patients following radiation therapy (RT),
Ho et al. (1977b) observed 2 pre-
dominant patterns of changes in the
skin reactivity to the HKLy28 extracts.
A positive initial skin reaction to the
HKLy28 extract, becoming negative after
RT, was frequently associated with a
good prognosis, while a preponderance
of NPC patients with a bad prognosis
after RT showed persistence of a positive
skin reaction throughout the period of
observation. Our observations with the
biopsy extracts were also in harmony
with the results of Chu et al. (1967)
which suggested the existence of NPC-
related CMI. The antigenic specificity of
the NPC associated CMI observed with
both types of extract is of obvious
interest. However, as the extracts thus
far used to demonstrate such CMI status
were heterogeneous mixtures, the question
of antigenic specificity must therefore
await studies (now in progress) using
purified fractions of these extracts. We
are also testing similar extracts of the
EBV-negative lymphoblastoid BJAB
cells, and of biopsy specimens obtained
from the primary tumour sites of patients
with other cancers, in order to further
characterize the NPC-associated CMI ob-
served with our present extracts and to
see whether it is NPC- or EBV-related or
both.
The present observations with PPD
accord with those of Ho et al. (1977)
who used extracts of trichophyton and
monilia as the recall antigens. In both
instances, no apparent differences were
observed between the CMI responses of
NPC and control subjects to these recall
antigens. Chan et al. (1976) however,
observed that the responses of peripheral
leucocytes from NPC patients to PHA
stimulation and their skin reactions to
PPD were less than those from control
subjects. The reason for such apparent
discrepancy remains to be resolved.
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